The analyst advises avoiding Unilever due to concerns about management's lack of skin in the game, poor capital allocation, and the increasing competition from private labels. Despite a 4% dividend and a P/E of 20, the underlying industry is too competitive, and the company's restructuring efforts may not be enough to counter long-term risks.
“The management, the ownership, the Dutch pension funds, there is simply no skin in the game. They are there just for themselves, not for shareholders.”